Summary

The animal parasiticides market is expected to grow from USD 12.98 billion in 2026 to USD 17.50 billion by 2031, at a CAGR of 6.2%. This growth is driven by several key factors shaping the future of parasite prevention, including long-acting treatment solutions and precision-driven parasite management in veterinary care.


One of the most significant driving forces in the animal parasiticides market is the growing demand for more effective, targeted, and preventive parasite control strategies as veterinary healthcare professionals work to improve the accuracy, speed, and longevity of parasite control. As the trend in the companion animal healthcare industry continues to evolve to a data-driven and risk-based approach to parasite control, there is an increasing demand for high-quality parasiticides that can support precision dosing, resistance, and year-round protection. This has been further fueled by the use of analytics and digital health platforms, thus creating a demand for innovative and safe parasiticide products.

Pet owners face urgent demand for fast-acting, effective, and long-lasting solutions because parasite infestations, vector-borne diseases, and age-related pet vulnerability keep increasing in frequency. Veterinarians use advanced oral, topical, and injectable products to treat more patients while achieving better treatment results through reduced need for patient follow-ups. The rising parasite resistance problem and environmental parasite contamination issue compel scientists to develop new active ingredients and combination parasiticides for their research.

Formulation science and delivery system advancements, such as extended-release injectables, long-acting oral chewables, and enhanced topical formulations, are driving the market as they enhance efficacy, ease of use, and compliance. Such advancements enable effective preventive treatment, close treatment gaps, and improve real-world outcomes, thus accelerating the ongoing development and adoption of innovative solutions in the animal parasiticides market.

"By animal type, the companion animals segment is projected to exhibit a higher CAGR than the livestock segment during the forecast period."
The companion animals segment is expected to experience a high growth rate in the animal parasiticides market because of the rising number of pet owners, the increasing humanization of pets, and increased expenditures on preventive veterinary care. The growing awareness of parasite-borne diseases, combined with the strong adoption of year-round flea, tick, and heartworm prevention and innovative long-acting parasiticide products, has also fueled demand in this segment.

"By end user, the veterinary hospitals & clinics segment accounted for the largest market share in 2025."
In 2025, the veterinary hospitals & clinics segment dominated the animal parasiticides market because these facilities served as the main center for parasite control treatment delivery through their diagnostic and prescription capabilities. Pet owners and livestock producers depend on veterinarians to deliver expert product advice and preventive care solutions, which leads to increased sales of parasiticides at veterinary clinics. The combination of prescription-only products and advanced long-acting products, together with rising demand for routine check-ups and preventive care, has established veterinary hospitals and clinics as the primary distribution and treatment channel in the market.

“Latin America is expected to witness the highest growth rate during the forecast period.”
Latin America is projected to be the fastest-growing regional market for animal parasiticides during the forecast period. The region's high market growth can be attributed to the expansion of livestock production, the increase in companion animal ownership, and a growing awareness of parasite prevention and animal health. Year-round favorable parasite living conditions due to the region's climate, enhanced availability of veterinary services, and increased use of modern parasiticide products are all factors that are speeding up the market growth in the Latin American region.

Breakdown of supply-side primary interviews:
? By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
? By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
? By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:
? By End User: Veterinary Hospitals & Clinics (50%), Animal Farms (33%), and Home Care Settings (17%)
By Designation: Veterinarian/Chief Veterinary Officer (47%), Procurement/Purchasing Manager (22%), Head of Animal Health / Farm Manager (15%), and Others (16%)
? By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage
The market study covers the animal parasiticides market in various segments. It aims to estimate the size and growth potential of this market by type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:
? Analysis of key drivers (rising pet ownership and increased focus on preventive animal healthcare and growing prevalence of ecto- and endoparasites), restraints (strict regulations on parasiticide residues in food-producing animals and high cost of premium and combination parasiticide products), opportunities (development of long-acting, combination, and novel-delivery parasiticides and expansion of parasiticide adoption in emerging markets), and challenges (increasing parasite resistance to existing active ingredients and stringent regulatory approval processes and varying regional compliance requirements) influencing the growth of the animal parasiticides market.
? Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the animal parasiticides market.
? Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of animal parasiticide products across regions.
? Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the animal parasiticides market.
? Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the animal parasiticides market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 INCLUSIONS AND EXCLUSIONS 39
1.3.3 YEARS CONSIDERED 39
1.4 CURRENCY 39
1.5 STAKEHOLDERS 40
2 EXECUTIVE SUMMARY 42
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 42
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 43
2.3 DISRUPTIVE TRENDS IN ANIMAL PARASITICIDES MARKET 44
2.4 HIGH-GROWTH SEGMENTS 45
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 46
3 PREMIUM INSIGHTS 47
3.1 ANIMAL PARASITICIDES MARKET OVERVIEW 47
3.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2025) 48
3.3 ANIMAL PARASITICIDES MARKET: REGIONAL GROWTH OPPORTUNITIES 49
3.4 ANIMAL PARASITICIDES MARKET: REGION (2026?2031) 49
3.5 ANIMAL PARASITICIDES MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 50
4 MARKET OVERVIEW 51
4.1 INTRODUCTION 51
4.2 MARKET DYNAMICS 51
4.2.1 DRIVERS 52
4.2.1.1 Increasing zoonotic & vector-borne disease burden, creating mandatory treatment 52
4.2.1.2 Expanding companion animal population and pet ownership 53
4.2.1.3 Increasing demand for animal-derived food products 55
4.2.2 RESTRAINTS 57
4.2.2.1 Growing resistance to parasiticides 57
4.2.2.2 Stringent regulatory approval processes for veterinary drugs 58
4.2.3 OPPORTUNITIES 59
4.2.3.1 High growth potential of emerging economies 59
?
4.2.4 CHALLENGES 60
4.2.4.1 Uneven regulatory approval timelines across key markets,
creating access inequalities 60
4.2.4.2 Balancing animal welfare, productivity, and compliance requirements 60
4.3 UNMET NEEDS AND WHITE SPACES 61
4.4 INTERCONNECTED MARKET AND CROSS-SECTOR OPPORTUNITIES 62
4.4.1 INTERCONNECTED MARKETS 62
4.4.2 CROSS-SECTOR OPPORTUNITIES 63
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63
4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63
5 INDUSTRY TRENDS 64
5.1 PORTER’S FIVE FORCE ANALYSIS 64
5.1.1 THREAT OF NEW ENTRANTS 65
5.1.2 THREAT OF SUBSTITUTES 65
5.1.3 BARGAINING POWER OF SUPPLIERS 65
5.1.4 BARGAINING POWER OF BUYERS 66
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.2 MACROECONOMIC INDICATORS 67
5.2.1 INTRODUCTION 67
5.2.2 GDP TRENDS AND FORECAST 67
5.2.3 GDP, CURRENT PRICES (BILLIONS OF U.S. DOLLARS) 67
5.2.4 GDP: CURRENT PRICES (USD BILLION) 67
5.2.5 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY 68
5.2.6 TRENDS IN GLOBAL ANIMAL PARASITICIDES INDUSTRY 69
5.3 VALUE CHAIN ANALYSIS 69
5.4 ECOSYSTEM ANALYSIS 71
5.5 PRICING ANALYSIS 71
5.5.1 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES,
BY KEY PLAYER, 2023?2025 72
5.5.1.1 Average selling price trend of ectoparasiticides,
by key player, 2023?2025 72
5.5.1.2 Average selling price trend of endoparasiticides,
by key player, 2023?2025 73
5.5.1.3 Average selling price trend of endectocides,
by key player, 2023?2025 74
5.5.2 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY REGION, 2023?2025 75
5.5.2.1 Average selling price trend of pour-on ectoparasiticides
(USD per standard treatment unit), by region, 2023?2025 76
5.5.2.2 Average selling price trend of spray ectoparasiticides
(USD per standard treatment unit), by region, 2023?2025 77
5.5.2.3 Average selling price trend of tablet ectoparasiticides
(USD per standard treatment unit), by region, 2023?2025 77
5.5.2.4 Average selling price trend of endoparasiticide oral solids
(USD per standard treatment unit), by region, 2023?2025 77
5.5.2.5 Average selling price trend of injectable endectocides
(USD per standard treatment unit), by region, 2023?2025 78
5.6 TRADE ANALYSIS 78
5.6.1 IMPORT DATA FOR HS CODE 30, 2021?2025 78
5.6.2 IMPORT SCENARIO (HS CODE 30) 78
5.6.3 EXPORT DATA FOR HS CODE 30, 2021?2025 79
5.6.4 EXPORT SCENARIO (HS CODE 30) 79
5.7 KEY CONFERENCES AND EVENTS IN 2026?2027 80
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 81
5.9 INVESTMENT AND FUNDING SCENARIO 81
5.10 CASE STUDY ANALYSIS 82
5.10.1 CASE STUDY 1: BROAD-SPECTRUM COMBINATION ECTOPARASITICIDE + ENDOPARASITICIDE (ZOETIS ? SIMPARICA TRIO) 82
5.10.2 CASE STUDY 2: FIRST BROAD-SPECTRUM FELINE TOPICAL ENDECTOCIDE (BOEHRINGER INGELHEIM ? NEXGARD COMBO) 83
5.10.3 CASE STUDY 3: BROADEST-SPECTRUM CANINE ORAL PARASITICIDE WITH FOUR ACTIVE INGREDIENTS (ELANCO ? CREDELIO QUATTRO) 83
5.11 ANIMAL PARASITICIDES MARKET: IMPACT OF 2025 US TARIFF 84
5.11.1 INTRODUCTION 84
5.11.2 KEY TARIFF RATES 85
5.11.3 PRICE IMPACT ANALYSIS 85
5.11.4 IMPACT ON COUNTRY/REGION 86
5.11.5 IMPACT ON END USERS 89
5.11.5.1 Veterinary hospitals & clinics 89
5.11.5.2 Home care settings 89
5.11.5.3 Animal farms 89
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 90
6.1 TECHNOLOGY ANALYSIS 90
6.1.1 KEY EMERGING TECHNOLOGIES 90
6.1.1.1 Long-acting/Extended-release parasiticides 90
6.1.1.2 Novel multi-parasite combination therapies 91
6.1.2 COMPLEMENTARY TECHNOLOGIES 91
6.1.2.1 Immunomodulators for host-assisted parasitic control 91
6.1.2.2 Nanobiosensors and rapid diagnostics for parasitic detection 92
6.1.3 ADJACENT TECHNOLOGIES 92
6.1.3.1 Entomopathogenic Fungi (EPF) for ticks and ectoparasites 92
6.1.3.2 Precision livestock farming sensors and wearables 93
6.2 TECHNOLOGY/PRODUCT ROADMAP 93
?
6.3 PATENT ANALYSIS 95
6.3.1 PUBLICATION TRENDS FOR ANIMAL PARASITICIDES 95
6.3.1.1 Insights on patent publication trends, top applicants and jurisdiction for animal parasiticides, january 2015?may 2026 95
6.3.2 LIST OF MAJOR PATENTS, 2023?2026 97
6.4 FUTURE APPLICATIONS 98
6.4.1 PRECISION LIVESTOCK HEALTH MANAGEMENT 98
6.4.2 ONCOLOGY AND CHRONIC DISEASE MANAGEMENT 98
6.4.3 REPRODUCTIVE AND FERTILITY ENHANCEMENT IN LIVESTOCK 98
6.4.4 INTEGRATED DISEASE SURVEILLANCE AND OUTBREAK CONTROL 98
6.5 IMPACT OF AI/GENERATIVE AI ON ANIMAL PARASITICIDES MARKET 99
6.5.1 INTRODUCTION 99
6.5.2 MARKET POTENTIAL IN ANIMAL PARASITICIDES ECOSYSTEM 99
6.5.3 AI USE CASES 100
6.5.4 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET 100
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 102
7.1 DECISION-MAKING PROCESS 102
7.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA 103
7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 103
7.2.2 BUYING CRITERIA 105
7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 106
7.4 UNMET NEEDS IN VARIOUS END-USE SETTINGS 107
7.4.1 VETERINARY HOSPITALS & CLINICS 107
7.4.2 LIVESTOCK FARMS 107
7.4.3 HOME CARE SETTINGS 108
7.5 MARKET PROFITABILITY 108
7.5.1 PRODUCT INNOVATION AND DIFFERENTIATION 108
7.5.2 EXPANSION OF COMPANION ANIMAL HEALTHCARE SPENDING 108
7.5.3 OPERATIONAL SCALE AND DISTRIBUTION EFFICIENCY 108
8 SUSTAINABILITY AND REGULATORY LANDSCAPE 109
8.1 REGULATORY LANDSCAPE 109
8.1.1 REGULATORY FRAMEWORK 109
8.1.1.1 North America 109
8.1.1.2 Europe 109
8.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 110
8.1.3 INDUSTRY STANDARDS 113
8.1.3.1 VICH Guidelines (International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products) 113
8.1.3.2 Good Manufacturing Practice (GMP) Standards ? PIC/S Guide (PE 009 series) 113
8.1.3.3 Codex Alimentarius Standards for Veterinary Drug Residues (CXM 2 ? Maximum Residue Limits) 113
8.2 SUSTAINABILITY INITIATIVES 113
8.2.1 ENERGY-EFFICIENT MANUFACTURING & CARBON REDUCTION IN ANIMAL PARASITICIDES MARKET 113
8.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 114
8.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 115
9 ANIMAL PARASITICIDES MARKET, BY TYPE 116
9.1 INTRODUCTION 117
9.2 ECTOPARASITICIDES 118
9.2.1 POUR-ONS & SPOT-ONS 121
9.2.1.1 Ease of application and broad spectrum activity to drive continued adoption 121
9.2.1.2 Global volume analysis of pour-ons & spot-ons, 2024?2031 (Thousand Units) 122
9.2.2 ORAL TABLETS 124
9.2.2.1 High medication compliance and ease of administration
to drive market 124
9.2.2.2 Global Volume Analysis of oral tablets, 2024?2031 (Thousand Units) 125
9.2.3 SPRAYS 126
9.2.3.1 Low price and convenience to drive market in emerging economies and livestock sector 126
9.2.3.2 Global Volume Analysis of sprays, 2024?2031 (Thousand Units) 127
9.2.4 DIPS 128
9.2.4.1 High popularity ensures sustained end-user demand 128
9.2.4.2 Global Volume Analysis of DIPS, 2024?2031 (Thousand Units) 129
9.2.5 EAR TAGS 131
9.2.5.1 High effectiveness in controlling flies around cattle drives market 131
9.2.5.2 Global Volume Analysis of ear tags, 2024?2031 (Thousand Units) 132
9.2.6 COLLARS 133
9.2.6.1 Growing prevalence of infections in companion animals to drive adoption 133
9.2.6.2 Global Volume Analysis of collars market, 2024?2031
(Thousand Units) 134
9.2.7 OTHER ECTOPARASITICIDES 135
9.3 ENDOPARASITICIDES 136
9.3.1 ORAL LIQUIDS 139
9.3.1.1 Broad-spectrum activity to drive adoption across young animals and intensive livestock systems 139
9.3.1.2 Global volume analysis of oral liquids, 2024?2031 (Thousand Units) 140
9.3.2 ORAL SOLIDS 142
9.3.2.1 Emergence of internal parasitic infections in dogs to drive market 142
9.3.2.2 Global volume analysis of oral solids, 2024?2031 (Thousand Units) 143
?
9.3.3 INJECTABLES 144
9.3.3.1 Global volume analysis of injectables, 2024?2031 (Thousand Units) 144
9.3.3.2 Standard/Short-acting injectables 146
9.3.3.2.1 Veterinary preference for fast-acting injectable formulations in acute parasitic infections drives market growth 146
9.3.3.3 Long-acting/Extended-release injectables 148
9.3.3.3.1 Emergence of internal parasitic infections in dogs
to drive market 148
9.3.4 FEED ADDITIVES 149
9.3.4.1 Can be administered to large number of animals at once 149
9.3.4.2 Global volume analysis of feed additives, 2024?2031
(Thousand Units) 150
9.3.5 OTHER ENDOPARASITICIDES 152
9.4 ENDECTOCIDES 153
9.4.1 ORAL ENDECTOCIDES 155
9.4.1.1 Growing pet owner preference for systemic all-in-one protection to accelerate oral endectocide demand 155
9.4.1.2 Global volume analysis of oral endectocides, 2024?2031
(Thousand Units) 156
9.4.2 INJECTABLE ENDECTOCIDES 158
9.4.2.1 Single-injection dual-action convenience underpins dominance in cattle and swine production systems 158
9.4.2.2 Global volume analysis of injectable endectocides, 2024?2031 (Thousand Units) 159
9.4.3 TOPICAL ENDECTOCIDES 160
9.4.3.1 Convenience, zero-injection compliance, and expanding multi-spectrum topical formulations sustain demand 160
9.4.3.2 Global volume analysis of topical endectocides, 2024?2031 (Thousand Units) 161
10 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE 163
10.1 INTRODUCTION 164
10.2 COMPANION ANIMALS 164
10.2.1 DOGS 167
10.2.1.1 Increasing adoption of dogs to drive market growth 167
10.2.2 CATS 169
10.2.2.1 Rising feline parasiticide adoption, low preventive compliance, and broad-spectrum product launches drive growth 169
10.2.3 HORSES 170
10.2.3.1 Higher risk of traumatic injuries in horses to drive demand 170
10.2.4 OTHER COMPANION ANIMALS 172
10.3 LIVESTOCK ANIMALS 173
10.3.1 CATTLE 176
10.3.1.1 Gastrointestinal nematodes and tick-borne disease drive systemic endectocide and acaricide demand 176
10.3.2 PIG 177
10.3.2.1 Growing surgical volume for acute conditions in swine to drive market growth 177
10.3.3 POULTRY 178
10.3.3.1 Growing focus on infection prevention and flock health management propels growth 178
10.3.4 SHEEP & GOAT 180
10.3.4.1 Growth in consumption of sheep and goat meat to drive market 180
10.3.5 OTHER LIVESTOCK ANIMALS 181
11 ANIMAL PARASITICIDES MARKET, BY END USER 183
11.1 INTRODUCTION 184
11.2 VETERINARY HOSPITALS & CLINICS 184
11.2.1 VETERINARY HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD 184
11.3 ANIMAL FARMS 186
11.3.1 GROWING IMPORTANCE AND OPPORTUNITIES IN ON-FARM PARASITE MANAGEMENT 186
11.4 HOME CARE SETTINGS 187
11.4.1 RISING PET EXPENDITURE TO PROPEL MARKET GROWTH 187
12 ANIMAL PARASITICIDES MARKET, BY REGION 189
12.1 INTRODUCTION 190
12.2 NORTH AMERICA 191
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 191
12.2.2 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS,
BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 193
12.2.3 US 197
12.2.3.1 Surge in animal healthcare expenditure to boost market growth 197
12.2.4 CANADA 202
12.2.4.1 Growing pet ownership and increasing focus on preventive animal healthcare to drive market growth 202
12.3 EUROPE 205
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 206
12.3.2 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 207
12.3.3 GERMANY 211
12.3.3.1 Strong focus on animal welfare and advanced veterinary care
to drive market growth 211
12.3.4 UK 215
12.3.4.1 Increasing pet ownership and rising animal healthcare spending to propel market growth 215
12.3.5 FRANCE 219
12.3.5.1 High standards of veterinary care and technological advancements to support market growth 219
12.3.6 ITALY 223
12.3.6.1 Growing pet ownership awareness and increasing livestock population to drive market growth 223
12.3.7 SPAIN 227
12.3.7.1 Increasing awareness regarding animal health to drive market growth 227
12.3.8 NETHERLANDS 230
12.3.8.1 Growing pet ownership and strong livestock sector to support market growth 230
12.3.9 SWEDEN 234
12.3.9.1 Growing companion animal care and advanced veterinary infrastructure supporting market growth 234
12.3.10 POLAND 238
12.3.10.1 Rapid expansion of poultry production and export-oriented farming increases demand 238
12.3.11 REST OF EUROPE 242
12.4 ASIA PACIFIC 245
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 245
12.4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS,
BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 248
12.4.3 CHINA 252
12.4.3.1 China to register highest growth rate during forecast period 252
12.4.4 JAPAN 256
12.4.4.1 Rising pet care expenditure and increasing adoption of companion animals to drive market growth 256
12.4.5 INDIA 259
12.4.5.1 Increasing livestock population to propel market growth 259
12.4.6 AUSTRALIA 263
12.4.6.1 Growing companion animal ownership and rise in animal health awareness to support market growth 263
12.4.7 SOUTH KOREA 267
12.4.7.1 Growing pet ownership to favor growth 267
12.4.8 THAILAND 270
12.4.8.1 Growing focus on livestock health and disease prevention to drive market growth 270
12.4.9 NEW ZEALAND 274
12.4.9.1 Growing pet ownership and focus on preventive animal healthcare to support market growth 274
12.4.10 REST OF ASIA PACIFIC 278
12.5 LATIN AMERICA 282
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 282
12.5.2 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS,
BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 283
12.5.3 BRAZIL 287
12.5.3.1 Brazil to dominate Latin American market 287
12.5.4 MEXICO 291
12.5.4.1 Robust livestock base and growing companion animal care drive market 291
12.5.5 ARGENTINA 294
12.5.5.1 Expanding livestock production and increasing focus on disease prevention to drive market growth 294
12.5.6 REST OF LATIN AMERICA 298
12.6 MIDDLE EAST & AFRICA 302
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 302
12.6.2 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 303
12.7 GCC COUNTRIES 307
12.7.1 KINGDOM OF SAUDI ARABIA (KSA) 311
12.7.1.1 Market growth driven by Vision 2030 investments 311
12.7.2 UNITED ARAB EMIRATES (UAE) 314
12.7.2.1 Increasing focus on livestock health and companion animal care to support market growth 314
12.7.3 OTHER GCC COUNTRIES 318
12.7.4 REST OF MIDDLE EAST & AFRICA 322
13 COMPETITIVE LANDSCAPE 326
13.1 INTRODUCTION 326
13.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET 326
13.2 REVENUE ANALYSIS, 2023?2025 328
13.3 GLOBAL MARKET SHARE ANALYSIS, 2025 328
13.3.1 US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025 331
13.3.2 EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025 331
13.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 332
13.4.1 STARS 332
13.4.2 EMERGING LEADERS 332
13.4.3 PERVASIVE PLAYERS 332
13.4.4 PARTICIPANTS 332
13.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 334
13.4.5.1 Company footprint 334
13.4.5.2 Region footprint 335
13.4.5.3 Product type footprint 336
13.4.5.4 Animal type footprint 337
13.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 338
13.5.1 PROGRESSIVE COMPANIES 338
13.5.2 RESPONSIVE COMPANIES 338
13.5.3 DYNAMIC COMPANIES 338
13.5.4 STARTING BLOCKS 338
13.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 340
13.5.5.1 List of startups/SMEs 340
13.5.5.2 Competitive benchmarking of startups/SMEs 341
13.6 COMPANY VALUATION AND FINANCIAL METRICS 342
13.7 PRODUCT/BRAND COMPARISON 343
13.8 COMPETITIVE SITUATIONS & TRENDS 344
14 COMPANY PROFILES 347
14.1 KEY PLAYERS 347
14.1.1 ZOETIS INC. 347
14.1.1.1 Business overview 347
14.1.1.2 Products offered 349
14.1.1.3 Recent developments 349
14.1.1.3.1 Product launches & approvals 349
14.1.1.3.2 Expansions 350
14.1.1.3.3 Other developments 351
14.1.1.4 MnM view 351
14.1.1.4.1 Right to win 351
14.1.1.4.2 Strategic choices 351
14.1.1.4.3 Weaknesses and competitive threats 352
14.1.2 MERCK & CO., INC 353
14.1.2.1 Business overview 353
14.1.2.2 Products offered 354
14.1.2.3 Recent developments 356
14.1.2.3.1 Product launches & approvals 356
14.1.2.3.2 Deals 357
14.1.2.3.3 Expansions 357
14.1.2.4 MnM view 357
14.1.2.4.1 Right to win 357
14.1.2.4.2 Strategic choices 358
14.1.2.4.3 Weaknesses and competitive threats 358
14.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 359
14.1.3.1 Business overview 359
14.1.3.2 Products offered 360
14.1.3.3 Recent developments 361
14.1.3.3.1 Product launches & approvals 361
14.1.3.3.2 Deals 362
14.1.3.3.3 Expansions 362
14.1.3.4 MnM view 363
14.1.3.4.1 Right to win 363
14.1.3.4.2 Strategic choices 363
14.1.3.4.3 Weaknesses and competitive threats 363
?
14.1.4 ELANCO 364
14.1.4.1 Business overview 364
14.1.4.2 Products offered 365
14.1.4.3 Recent developments 367
14.1.4.3.1 Product launches & approvals 367
14.1.4.3.2 Expansions 368
14.1.4.3.3 Other developments 369
14.1.4.4 MnM view 369
14.1.4.4.1 Right to win 369
14.1.4.4.2 Strategic choices 369
14.1.4.4.3 Weaknesses and competitive threats 370
14.1.5 VIRBAC 371
14.1.5.1 Business overview 371
14.1.5.2 Products offered 373
14.1.5.3 Recent developments 374
14.1.5.3.1 Product launches & approvals 374
14.1.5.3.2 Deal 374
14.1.5.4 MnM view 374
14.1.5.4.1 Right to win 374
14.1.5.4.2 Strategic choices 375
14.1.5.4.3 Weaknesses and competitive threats 375
14.1.6 CEVA 376
14.1.6.1 Business overview 376
14.1.6.2 Products offered 376
14.1.6.3 Recent developments 377
14.1.6.3.1 Deals 377
14.1.6.3.2 Expansions 378
14.1.7 VETOQUINOL 379
14.1.7.1 Business overview 379
14.1.7.2 Products offered 381
14.1.8 NORBROOK 382
14.1.8.1 Business overview 382
14.1.8.2 Products offered 382
14.1.8.3 Recent developments 383
14.1.8.3.1 Product launches & approvals 383
14.1.8.3.2 Expansions 384
14.1.9 BIMEDA CORPORATE 385
14.1.9.1 Business overview 385
14.1.9.2 Products offered 385
14.1.9.3 Recent developments 386
14.1.9.3.1 Product launches & approvals 386
14.1.9.3.2 Deals 386
14.1.9.3.3 Expansions 387
14.1.10 KYORITSU SEIYAKU CORPORATION 388
14.1.10.1 Business overview 388
14.1.10.2 Products offered 388
14.1.11 KRKA, D. D., NOVO MESTO 390
14.1.11.1 Business overview 390
14.1.11.2 Products offered 391
14.1.12 ECO - ANIMAL HEALTH LTD. 393
14.1.12.1 Business overview 393
14.1.12.2 Products offered 394
14.1.13 ALIVIRA ANIMAL HEALTH LIMITED 395
14.1.13.1 Business overview 395
14.1.13.2 Products offered 395
14.1.13.2.1 Recent developments 396
14.1.13.2.2 Deals 396
14.1.14 OUROFINO SA?DE ANIMAL 397
14.1.14.1 Business overview 397
14.1.14.2 Products offered 398
14.1.15 HEBEI VEYONG PHARMACEUTICAL CO., LTD. 399
14.1.15.1 Business overview 399
14.1.15.2 Products offered 399
14.2 OTHER PLAYERS 401
14.2.1 CHANELLE PHARMA 401
14.2.2 PETIQ LLC 402
14.2.3 HUVEPHARMA 403
14.2.4 CALIER 404
14.2.5 ABBEY LABS 405
14.2.6 BIOG?NESIS BAG? 406
14.2.7 VETANCO SA 407
14.2.8 HESTER BIOSCIENCES LIMITED 408
14.2.9 BRILLIANT BIO PHARMA 409
14.2.10 ASHISH LIFE SCIENCE 410
15 RESEARCH METHODOLOGY 412
15.1 RESEARCH APPROACH 412
15.2 RESEARCH METHODOLOGY DESIGN 412
15.2.1 SECONDARY RESEARCH 413
15.2.1.1 Key data from secondary sources 414
15.2.2 PRIMARY DATA 414
15.2.2.1 Key data from primary sources 415
15.2.2.2 Key industry insights 416
?
15.3 MARKET SIZE ESTIMATION 418
15.3.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 418
15.3.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 420
15.3.3 APPROACH 3: DEMAND-SIDE ANALYSIS 420
15.3.4 APPROACH 4: TOP-DOWN APPROACH 421
15.3.5 APPROACH 5: BOTTOM-UP APPROACH 422
15.4 MARKET BREAKDOWN & DATA TRIANGULATION 425
15.5 MARKET SHARE ESTIMATION 425
15.6 RESEARCH ASSUMPTIONS 426
15.7 RISK ASSESSMENT 426
15.8 RESEARCH LIMITATIONS 427
15.8.1 METHODOLOGY-RELATED LIMITATIONS 427
15.8.2 SCOPE-RELATED LIMITATIONS 427
16 APPENDIX 428
16.1 DISCUSSION GUIDE 428
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 434
16.3 CUSTOMIZATION OPTIONS 436
16.3.1 PRODUCT ANALYSIS 436
16.3.2 COMPANY INFORMATION 436
16.3.3 GEOGRAPHIC ANALYSIS 436
16.3.4 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT 436
16.3.5 BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 436
16.3.6 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 436
16.4 RELATED REPORTS 437
16.5 AUTHOR DETAILS 438

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 39
TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2025 53
TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION 54
TABLE 4 TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED &
EMERGING ECONOMIES 56
TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED
FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 56
TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS,
2020 VS. 2030 (THOUSAND METRIC TONS) 57
TABLE 7 PARASITICIDES AND RESISTANT PARASITES 58
TABLE 8 UNMET CUSTOMER NEEDS AND WHITE SPACES IN ANIMAL
PARASITICIDES MARKET. 61
TABLE 9 INTERCONNECTED MARKETS IN ANIMAL PARASITICIDES MARKET 62
TABLE 10 CROSS-SECTOR MARKETS IN ANIMAL PARASITICIDES MARKET 63
TABLE 11 ANIMAL PARASITICIDES MARKET: PORTER’S FIVE FORCES ANALYSIS 64
TABLE 12 AVERAGE SELLING PRICE TREND OF ECTOPARASITICIDES,
BY KEY PLAYER, 2023?2025 72
TABLE 13 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDES,
BY KEY PLAYER, 2023?2025 73
TABLE 14 AVERAGE SELLING PRICE TREND OF ENDECTOCIDES, BY KEY PLAYER, 2023?2025 74
TABLE 15 AVERAGE SELLING PRICE TREND OF POUR-ON ECTOPARASITICIDES, BY REGION, 2023?2025 76
TABLE 16 AVERAGE SELLING PRICE TREND OF SPRAY ECTOPARASITICIDES, BY REGION, 2023?2025 77
TABLE 17 AVERAGE SELLING PRICE TREND OF TABLET ECTOPARASITICIDES, BY REGION, 2023?2025 77
TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDE ORAL SOLIDS,
BY REGION, 2023?2025 77
TABLE 19 AVERAGE SELLING PRICE TREND OF INJECTABLE ENDECTOCIDES,
BY REGION, 2023?2025 78
TABLE 20 IMPORT DATA FOR HS CODE 30, BY COUNTRY, 2021?2025 (USD THOUSAND) 78
TABLE 21 EXPORT DATA FOR HS CODE 30, BY COUNTRY, 2021?2025 (USD THOUSAND) 79
TABLE 22 ANIMAL PARASITICIDES MARKET: KEY CONFERENCES AND EVENTS 80
TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES 85
TABLE 24 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 86
TABLE 25 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 87
TABLE 26 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 88
TABLE 27 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 88
TABLE 28 ANIMAL PARASITICIDES MARKET: MAJOR PATENTS, JANUARY 2022?MAY 2026 97
TABLE 29 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET 101
TABLE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL PARASITICIDES 104
TABLE 31 KEY BUYING CRITERIA FOR CLASS OF DEVICES 105
TABLE 32 ANIMAL PARASITICIDES MARKET: UNMET NEEDS IN KEY END-USE SETTINGS 107
TABLE 33 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 110
TABLE 34 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 111
TABLE 35 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 112
TABLE 36 REST OF WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 112
TABLE 37 ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 117
TABLE 38 COMPANION ANIMALS ? FLEA & TICK BURDEN 118
TABLE 39 ECTOPARASITICIDES AVAILABLE IN MARKET 119
TABLE 40 ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 120
TABLE 41 ECTOPARASITICIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 120
TABLE 42 KEY PLAYERS PROVIDING POUR-ONS & SPOT-ONS 122
TABLE 43 GLOBAL VOLUME ANALYSIS OF POUR-ONS & SPOT-ONS, 2024?2031
(THOUSAND UNITS) 122
TABLE 44 POUR-ONS & SPOT-ONS: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 123
TABLE 45 KEY PLAYERS PROVIDING ORAL TABLETS 124
TABLE 46 GLOBAL VOLUME ANALYSIS OF ORAL TABLETS, 2024?2031 (THOUSAND UNITS) 125
TABLE 47 ORAL TABLETS: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 125
TABLE 48 KEY PLAYERS PROVIDING SPRAYS 126
TABLE 49 GLOBAL VOLUME ANALYSIS OF SPRAYS, 2024?2031 (THOUSAND UNITS) 127
TABLE 50 SPRAYS: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 127
TABLE 51 KEY PLAYERS PROVIDING DIPS 129
TABLE 52 GLOBAL VOLUME ANALYSIS OF DIPS, 2024?2031 (THOUSAND UNITS) 129
TABLE 53 DIPS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 130
TABLE 54 KEY PLAYERS PROVIDING TAGS 131
TABLE 55 GLOBAL VOLUME ANALYSIS OF EAR TAGS, 2024?2031 (THOUSAND UNITS) 132
TABLE 56 EARTAG: ANIMAL PARASITICIDES TAGS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 132
TABLE 57 KEY PLAYERS PROVIDING COLLARS 133
TABLE 58 GLOBAL VOLUME ANALYSIS OF COLLARS MARKET,
2024?2031 (THOUSAND UNITS) 134
TABLE 59 COLLARS: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 134
TABLE 60 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 135
TABLE 61 ENDOPARASITICIDES AVAILABLE IN MARKET 137
TABLE 62 ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 138
TABLE 63 ENDOPARASITICIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 138
TABLE 64 KEY PLAYERS PROVIDING ORAL LIQUIDS 139
TABLE 65 GLOBAL VOLUME ANALYSIS OF ORAL LIQUIDS, 2024?2031 (THOUSAND UNITS) 140
TABLE 66 ORAL LIQUIDS: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 141
TABLE 67 KEY PLAYERS PROVIDING ORAL SOLIDS 142
TABLE 68 GLOBAL VOLUME ANALYSIS OF ORAL SOLIDS, 2024?2031 (THOUSAND UNITS) 143
TABLE 69 ORAL: ANIMAL PARASITICIDES SOLIDS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 143
TABLE 70 GLOBAL VOLUME ANALYSIS OF INJECTABLES, 2024?2031 (THOUSAND UNITS) 144
TABLE 71 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 145
TABLE 72 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 145
TABLE 73 KEY PLAYERS PROVIDING STANDARD/SHORT-ACTING INJECTABLES 146
TABLE 74 STANDARD/SHORT-ACTING INJECTABLES: ANIMAL PARASITICIDES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 147
TABLE 75 KEY PLAYERS PROVIDING LONG-ACTING/EXTENDED-RELEASE INJECTABLES 148
TABLE 76 LONG-ACTING/EXTENDED-RELEASE INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 148
TABLE 77 KEY PLAYERS PROVIDING FEED ADDITIVES 149
TABLE 78 GLOBAL VOLUME ANALYSIS OF FEED ADDITIVES, 2024?2031 (THOUSAND UNITS) 150
TABLE 79 FEED ADDITIVES: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 151
TABLE 80 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 152
TABLE 81 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET 153
TABLE 82 ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 154
TABLE 83 ENDECTOCIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 154
TABLE 84 KEY PLAYERS PROVIDING ORAL ENDECTOCIDES 156
TABLE 85 GLOBAL VOLUME ANALYSIS OF ORAL ENDECTOCIDES,
2024?2031 (THOUSAND UNITS) 156
TABLE 86 ORAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 157
TABLE 87 KEY PLAYERS PROVIDING INJECTABLE ENDECTOCIDES 158
TABLE 88 GLOBAL VOLUME ANALYSIS OF INJECTABLE ENDECTOCIDES,
2024?2031 (THOUSAND UNITS) 159
TABLE 89 INJECTABLE ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 159
TABLE 90 KEY PLAYERS PROVIDING TOPICAL ENDECTOCIDES 160
TABLE 91 GLOBAL VOLUME ANALYSIS OF TOPICAL ENDECTOCIDES,
2024?2031 (THOUSAND UNITS) 161
TABLE 92 TOPICAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 161
TABLE 93 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024?2031 (USD MILLION) 164
TABLE 94 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY TYPE,
2024?2031 (USD MILLION) 165
TABLE 95 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY COUNTRY,
2024?2031 (USD MILLION) 166
TABLE 96 ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY,
2024?2031 (USD MILLION) 168
TABLE 97 ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY,
2024?2031 (USD MILLION) 169
TABLE 98 ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY,
2024?2031 (USD MILLION) 171
TABLE 99 PARASITICIDE APPLICATIONS ACROSS OTHER COMPANION ANIMAL SPECIES 172
TABLE 100 ANIMAL PARASITICIDES MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024?2031 (USD MILLION) 172
TABLE 101 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY TYPE,
2024?2031 (USD MILLION) 174
TABLE 102 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,
2024?2031 (USD MILLION) 175
TABLE 103 ANIMAL PARASITICIDES MARKET FOR CATTLE, BY COUNTRY,
2024?2031 (USD MILLION) 176
TABLE 104 ANIMAL PARASITICIDES MARKET FOR PIG, BY COUNTRY,
2024?2031 (USD MILLION) 177
TABLE 105 ANIMAL PARASITICIDES MARKET FOR POULTRY, BY COUNTRY,
2024?2031 (USD MILLION) 179
TABLE 106 ANIMAL PARASITICIDES MARKET FOR SHEEP & GOAT, BY COUNTRY,
2024?2031 (USD MILLION) 180
TABLE 107 ANIMAL PARASITICIDES MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024?2031 (USD MILLION) 181
TABLE 108 ANIMAL PARASITICIDES MARKET, BY END USER, 2024?2031 (USD MILLION) 184
TABLE 109 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS & CLINICS,
BY COUNTRY, 2024?2031 (USD MILLION) 185
TABLE 110 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY,
2024?2031 (USD MILLION) 186
TABLE 111 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2024?2031 (USD MILLION) 188
TABLE 112 ANIMAL PARASITICIDES MARKET, BY REGION, 2024?2031 (USD MILLION) 191
TABLE 113 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS,
BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 193
TABLE 114 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 194
TABLE 115 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 194
TABLE 116 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 195
TABLE 117 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 195
TABLE 118 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 195
TABLE 119 NORTH AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 196
TABLE 120 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 196
TABLE 121 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024?2031 (USD MILLION) 196
TABLE 122 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 197
TABLE 123 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 197
TABLE 124 US: KEY MACROINDICATORS 198
TABLE 125 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 199
TABLE 126 US: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 199
TABLE 127 US: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 199
TABLE 128 US: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 200
TABLE 129 US: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 200
TABLE 130 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 200
TABLE 131 US: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 201
TABLE 132 US: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 201
TABLE 133 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2024?2031 (USD MILLION) 201
TABLE 134 CANADA: KEY MACROINDICATORS 202
TABLE 135 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 202
TABLE 136 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 203
TABLE 137 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 203
TABLE 138 CANADA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 203
TABLE 139 CANADA: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 204
TABLE 140 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 204
TABLE 141 CANADA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 204
TABLE 142 CANADA ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 205
TABLE 143 CANADA ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 205
TABLE 144 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 207
TABLE 145 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 208
TABLE 146 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 208
TABLE 147 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 209
TABLE 148 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 209
TABLE 149 EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 209
TABLE 150 EUROPE: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 210
TABLE 151 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 210
TABLE 152 EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 210
TABLE 153 EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 211
TABLE 154 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 211
TABLE 155 GERMANY: KEY MACROINDICATORS 212
TABLE 156 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 212
TABLE 157 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 213
TABLE 158 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 213
TABLE 159 GERMANY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 213
TABLE 160 GERMANY: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 214
TABLE 161 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 214
TABLE 162 GERMANY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 214
TABLE 163 GERMANY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 215
TABLE 164 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 215
TABLE 165 UK: KEY MACROINDICATORS 216
TABLE 166 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 216
TABLE 167 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 217
TABLE 168 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 217
TABLE 169 UK: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 217
TABLE 170 UK: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 218
TABLE 171 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 218
TABLE 172 UK: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 218
TABLE 173 UK: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 219
TABLE 174 UK ANIMAL PARASITICIDES MARKET, BY END USER, 2024?2031 (USD MILLION) 219
TABLE 175 FRANCE: KEY MACROINDICATORS 220
TABLE 176 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 220
TABLE 177 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 220
TABLE 178 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 221
TABLE 179 FRANCE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 221
TABLE 180 FRANCE: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 221
TABLE 181 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 222
TABLE 182 FRANCE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 222
TABLE 183 FRANCE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 222
TABLE 184 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 223
TABLE 185 ITALY: KEY MACROINDICATORS 223
TABLE 186 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 187 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 188 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 189 ITALY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 225
TABLE 190 ITALY: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 225
TABLE 191 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 225
TABLE 192 ITALY: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 226
TABLE 193 ITALY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 226
TABLE 194 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 226
TABLE 195 SPAIN: KEY MACROINDICATORS 227
TABLE 196 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 227
TABLE 197 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 228
TABLE 198 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 228
TABLE 199 SPAIN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 228
TABLE 200 SPAIN: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 229
TABLE 201 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 229
TABLE 202 SPAIN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 229
TABLE 203 SPAIN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 230
TABLE 204 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 230
TABLE 205 NETHERLANDS: KEY MACROINDICATORS 231
TABLE 206 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 231
TABLE 207 NETHERLANDS: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 232
TABLE 208 NETHERLANDS: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 232
TABLE 209 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 232
TABLE 210 NETHERLANDS: ENDECTOCIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 233
TABLE 211 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 233
TABLE 212 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 233
TABLE 213 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 234
TABLE 214 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 234
TABLE 215 SWEDEN: KEY MACRO INDICATORS 235
TABLE 216 SWEDEN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 235
TABLE 217 SWEDEN: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 235
TABLE 218 SWEDEN: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 236
TABLE 219 SWEDEN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 236
TABLE 220 SWEDEN: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 236
TABLE 221 SWEDEN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 237
TABLE 222 SWEDEN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 237
TABLE 223 SWEDEN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 237
TABLE 224 SWEDEN: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 238
TABLE 225 POLAND: KEY MACRO INDICATORS 238
TABLE 226 POLAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 239
TABLE 227 POLAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 239
TABLE 228 POLAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 239
TABLE 229 POLAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 240
TABLE 230 POLAND: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 240
TABLE 231 POLAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 240
TABLE 232 POLAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 241
TABLE 233 POLAND ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 241
TABLE 234 POLAND: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 241TABLE 235 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 242
TABLE 236 REST OF EUROPE: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 242
TABLE 237 REST OF EUROPE: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 243
TABLE 238 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 243
TABLE 239 REST OF EUROPE: ENDECTOCIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 243
TABLE 240 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 244
TABLE 241 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024?2031 (USD MILLION) 244
TABLE 242 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024?2031 (USD MILLION) 244
TABLE 243 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 245
TABLE 244 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 248
TABLE 245 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 248
TABLE 246 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 249
TABLE 247 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 249
TABLE 248 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 249
TABLE 249 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 250
TABLE 250 ASIA PACIFIC: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 250
TABLE 251 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 250
TABLE 252 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 251
TABLE 253 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 251
TABLE 254 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 251
TABLE 255 CHINA: KEY MACROINDICATORS 252
TABLE 256 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 253
TABLE 257 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 253
TABLE 258 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 253
TABLE 259 CHINA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 254
TABLE 260 CHINA: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 254
TABLE 261 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 254
TABLE 262 CHINA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 255
TABLE 263 CHINA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 255
TABLE 264 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 255
TABLE 265 JAPAN: KEY MACROINDICATORS 256
TABLE 266 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 256
TABLE 267 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 257
TABLE 268 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 257
TABLE 269 JAPAN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 257
TABLE 270 JAPAN: ENDECTOCIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 258
TABLE 271 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 258
TABLE 272 JAPAN ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 258
TABLE 273 JAPAN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 259
TABLE 274 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 259
TABLE 275 INDIA: KEY MACROINDICATORS 260
TABLE 276 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 260
TABLE 277 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 261
TABLE 278 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 261
TABLE 279 INDIA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 261
TABLE 280 INDIA: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 262
TABLE 281 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 262
TABLE 282 INDIA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 262
TABLE 283 INDIA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 263
TABLE 284 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 263
TABLE 285 AUSTRALIA: KEY MACROINDICATORS 264
TABLE 286 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 264
TABLE 287 AUSTRALIA: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 264
TABLE 288 AUSTRALIA: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 289 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 265
TABLE 290 AUSTRALIA: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 291 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 266
TABLE 292 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 266
TABLE 293 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 266
TABLE 294 AUSTRALIA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 267
TABLE 295 SOUTH KOREA: KEY MACROINDICATORS 267
TABLE 296 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 267
TABLE 297 SOUTH KOREA: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 268
TABLE 298 SOUTH KOREA: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 268
TABLE 299 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 268
TABLE 300 SOUTH KOREA: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 269
TABLE 301 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 269
TABLE 302 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 269
TABLE 303 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 270
TABLE 304 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 270
TABLE 305 THAILAND: KEY MACROINDICATORS 271
TABLE 306 THAILAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 271
TABLE 307 THAILAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 272
TABLE 308 THAILAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 272
TABLE 309 THAILAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 272
TABLE 310 THAILAND: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 273
TABLE 311 THAILAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 273
TABLE 312 THAILAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 273
TABLE 313 THAILAND: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 274
TABLE 314 THAILAND: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 274
TABLE 315 NEW ZEALAND: KEY MACROINDICATORS 275
TABLE 316 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 275
TABLE 317 NEW ZEALAND: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 276
TABLE 318 NEW ZEALAND: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 276
TABLE 319 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 276
TABLE 320 NEW ZEALAND: ENDECTOCIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 277
TABLE 321 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 277
TABLE 322 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 277
TABLE 323 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 278
TABLE 324 NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 278
TABLE 325 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 279
TABLE 326 REST OF ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 279
TABLE 327 REST OF ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 280
TABLE 328 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024?2031 (USD MILLION) 280
TABLE 329 REST OF ASIA PACIFIC: ENDECTOCIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 280
TABLE 330 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 281
TABLE 331 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024?2031 (USD MILLION) 281
TABLE 332 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024?2031 (USD MILLION) 281
TABLE 333 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 282
TABLE 334 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 283
TABLE 335 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 284
TABLE 336 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 284
TABLE 337 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 284
TABLE 338 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 285
TABLE 339 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 285
TABLE 340 LATIN AMERICA: ENDECTOCIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 285
TABLE 341 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 286
TABLE 342 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 286
TABLE 343 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 286
TABLE 344 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 287
TABLE 345 BRAZIL: KEY MACROINDICATORS 287
TABLE 346 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 288
TABLE 347 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 288
TABLE 348 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 288
TABLE 349 BRAZIL: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 289
TABLE 350 BRAZIL: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 289
TABLE 351 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 289
TABLE 352 BRAZIL: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 290
TABLE 353 BRAZIL: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 290
TABLE 354 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 290
TABLE 355 MEXICO: KEY MACROINDICATORS 291
TABLE 356 MEXICO: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 291
TABLE 357 MEXICO: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 292
TABLE 358 MEXICO: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 292
TABLE 359 MEXICO: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 292
TABLE 360 MEXICO: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 293
TABLE 361 MEXICO: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 293
TABLE 362 MEXICO: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 293
TABLE 363 MEXICO: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 294
TABLE 364 MEXICO: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 294
TABLE 365 ARGENTINA: KEY MACROINDICATORS 295
TABLE 366 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 295
TABLE 367 ARGENTINA: ECTOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 296
TABLE 368 ARGENTINA: ENDOPARASITICIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 296
TABLE 369 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 296
TABLE 370 ARGENTINA: ENDECTOCIDES MARKET, BY TYPE, 2024?2031 (USD MILLION) 297
TABLE 371 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 297
TABLE 372 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL,
2024?2031 (USD MILLION) 297
TABLE 373 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL,
2024?2031 (USD MILLION) 298
TABLE 374 ARGENTINA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 298
TABLE 375 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 299
TABLE 376 REST OF LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 299
TABLE 377 REST OF LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 300
TABLE 378 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE,
2024?2031 (USD MILLION) 300
TABLE 379 REST OF LATIN AMERICA: ENDECTOCIDES MARKET, BY TYPE,
2024?2031 (USD MILLION) 300
TABLE 380 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 301
TABLE 381 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024?2031 (USD MILLION) 301
TABLE 382 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024?2031 (USD MILLION) 301
TABLE 383 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER,
2024?2031 (USD MILLION) 302
TABLE 384 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024?2031 (THOUSAND UNITS) 303
TABLE 385 MIDDLE EAST & AFRIC